Kimia Biosciences Limited (BOM:530313)
33.29
-3.21 (-8.79%)
At close: Jun 1, 2026
Kimia Biosciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 8.2 | 2.06 | 1.48 | 1.78 | 2.05 |
Trading Asset Securities | - | - | - | 0.63 | 0.6 |
Cash & Short-Term Investments | 8.2 | 2.06 | 1.48 | 2.41 | 2.65 |
Cash Growth | 297.87% | 39.63% | -38.73% | -9.20% | -58.87% |
Accounts Receivable | 293.2 | 367.51 | 275.54 | 305.9 | 302.01 |
Other Receivables | 7.56 | 7.5 | 5.36 | 5.78 | 36.69 |
Receivables | 300.76 | 375.01 | 280.9 | 311.67 | 338.7 |
Inventory | 262.58 | 345.83 | 308.04 | 482.34 | 370.18 |
Prepaid Expenses | - | 2.15 | 1.32 | 1.42 | 3.15 |
Other Current Assets | 64.66 | 27.87 | 22.35 | 29.63 | 16.01 |
Total Current Assets | 636.2 | 752.92 | 614.08 | 827.47 | 730.7 |
Property, Plant & Equipment | 303.96 | 309.02 | 323.8 | 341.53 | 350.82 |
Other Intangible Assets | 70.99 | 0.22 | 0.41 | 0.85 | 1.45 |
Long-Term Deferred Tax Assets | 6.28 | 17.63 | 57.84 | 39.69 | 9.08 |
Long-Term Deferred Charges | - | 23.57 | - | - | - |
Other Long-Term Assets | 14.54 | 8.77 | 3.54 | 3.64 | 2.86 |
Total Assets | 1,032 | 1,112 | 999.67 | 1,213 | 1,095 |
Accounts Payable | 422.15 | 504.89 | 399.88 | 465.86 | 402.06 |
Accrued Expenses | - | 51.61 | 57.55 | 50.93 | 29.71 |
Short-Term Debt | 118.19 | 196.38 | 197.91 | 198.32 | 148.1 |
Current Portion of Long-Term Debt | - | 25.58 | 22.01 | 22.52 | 13.6 |
Current Portion of Leases | 1.08 | 1.86 | 1.21 | - | - |
Current Unearned Revenue | - | 37.93 | 15.03 | 22.97 | 16.99 |
Other Current Liabilities | 70.42 | 0 | 0.79 | 3.38 | 7.56 |
Total Current Liabilities | 611.84 | 818.25 | 694.38 | 763.98 | 618.02 |
Long-Term Debt | 228.09 | 167 | 272.17 | 361.63 | 293.33 |
Long-Term Leases | 0.49 | 2.76 | 1.85 | - | - |
Long-Term Unearned Revenue | - | 8.48 | 13.48 | 18.48 | 23.47 |
Pension & Post-Retirement Benefits | - | 14.15 | 12.68 | 12.53 | 11.21 |
Other Long-Term Liabilities | 14.35 | 1.81 | 1.81 | 1.92 | - |
Total Liabilities | 854.77 | 1,012 | 996.36 | 1,159 | 946.03 |
Common Stock | 47.31 | 47.31 | 47.31 | 47.31 | 47.31 |
Additional Paid-In Capital | - | 60.85 | 60.85 | 60.85 | 60.85 |
Retained Earnings | - | -8.5 | -104.86 | -53.54 | 40.72 |
Comprehensive Income & Other | 129.89 | - | - | - | - |
Total Common Equity | 177.21 | 99.66 | 3.31 | 54.63 | 148.88 |
Shareholders' Equity | 177.21 | 99.66 | 3.31 | 54.63 | 148.88 |
Total Liabilities & Equity | 1,032 | 1,112 | 999.67 | 1,213 | 1,095 |
Total Debt | 347.85 | 393.58 | 495.14 | 582.47 | 455.03 |
Net Cash (Debt) | -339.65 | -391.52 | -493.67 | -580.06 | -452.38 |
Net Cash Per Share | -7.49 | -8.28 | -10.43 | -12.26 | -9.56 |
Filing Date Shares Outstanding | 24.87 | 47.31 | 47.31 | 47.31 | 47.31 |
Total Common Shares Outstanding | 24.87 | 47.31 | 47.31 | 47.31 | 47.31 |
Working Capital | 24.37 | -65.33 | -80.3 | 63.49 | 112.68 |
Book Value Per Share | 7.12 | 2.11 | 0.07 | 1.15 | 3.15 |
Tangible Book Value | 106.21 | 99.44 | 2.9 | 53.78 | 147.44 |
Tangible Book Value Per Share | 4.27 | 2.10 | 0.06 | 1.14 | 3.12 |
Land | - | 4.75 | 4.75 | 4.75 | 4.75 |
Buildings | - | 61.17 | 61.17 | 60 | 60 |
Machinery | - | 423.4 | 401.66 | 390.95 | 373.58 |
Construction In Progress | - | 0.03 | 5.76 | 6.06 | - |